Dare Bioscience
DARE
22 hedge funds and large institutions have $2.08M invested in Dare Bioscience in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 11 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
7.07% more ownership
Funds ownership: 0.59% → 7.67% (+7.1%)
15% less capital invested
Capital invested by funds: $2.46M → $2.08M (-$378K)
19% less funds holding
Funds holding: 27 → 22 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AE
AMH Equity
Great Neck,
New York
|
+$78.7K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$47K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$46.7K |
| 4 |
FFS
Founders Financial Securities
Towson,
Maryland
|
+$39.6K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$35.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$34.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$25.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.7K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$10.4K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$10.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Charles Schwab
San Francisco,
California
| – | -$10.3K | -2,544 | Closed |
|
27
Bank of New York Mellon
New York
| – | -$8.72K | -2,162 | Closed |
|
28
Osaic Holdings
Scottsdale,
Arizona
| – | -$6.72K | -1,667 | Closed |
|
|
RJFSA
29
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$6.72K | -1,667 | Closed |
|
30
Jane Street
New York
| – | -$3.75K | -929 | Closed |
|
31
Cerity Partners
New York
| – | -$3.36K | -833 | Closed |
|
32
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.01K | -250 | Closed |
|
33
Fidelity Investments
Boston,
Massachusetts
| – | -$169 | -42 | Closed |
|
DARE Hedge Fund Activity: Q3 2024 in Review
22 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2024, worth a combined $2.08M — down 15% from $2.46M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DARE and 6 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 10 added.
The largest buyer was AMH Equity, adding an estimated $78.7K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $34.6K sold.
- 22 institutional investors held Dare Bioscience (DARE) as of Q3 2024, down from 27 in Q2 2024.
- Funds reported $2.08M of Dare Bioscience stock for Q3 2024, down 15% quarter-over-quarter.
- 6 funds opened new Dare Bioscience positions in Q3 2024 and 11 closed out, a net change of -5 holders.
- The largest Dare Bioscience buyer in Q3 2024 was AMH Equity, an estimated $78.7K added.
- The largest Dare Bioscience seller in Q3 2024 was Two Sigma Securities, an estimated $34.6K sold.
Based on aggregated 13F filings for Q3 2024.